M L Dahl - JoVE Visualize

Showing results (101-110 of 105) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 105 results.

FEBS Letters|November 25, 1998

Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidaseM Oscarson, H Gullstén, A Rautio, et al.

British Journal of Clinical Pharmacology|November 1, 1994

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine testL Bertilsson, J A Carrillo, M L Dahl, et al.

Pharmacogenetics|January 14, 2000

Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotypeA Wennerholm, I Johansson, A Y Massele, et al.

Clinical Pharmacology and Therapeutics|November 3, 1998

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotypeK Herrlin, A Y Massele, M Jande, et al.

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 12, 2021

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsC B Eap, G Gründer, P Baumann, et al.

Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 105 results.

FEBS Letters|November 25, 1998

Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidaseM Oscarson, H Gullstén, A Rautio, et al.

British Journal of Clinical Pharmacology|November 1, 1994

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine testL Bertilsson, J A Carrillo, M L Dahl, et al.

Pharmacogenetics|January 14, 2000

Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotypeA Wennerholm, I Johansson, A Y Massele, et al.

Clinical Pharmacology and Therapeutics|November 3, 1998

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotypeK Herrlin, A Y Massele, M Jande, et al.

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 12, 2021

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsC B Eap, G Gründer, P Baumann, et al.

Pageof 11